5 results
Primary Objective* To assess the safety, tolerability, and efficacy (in terms of change in DAS28 [using C-ReactiveProtein (CRP)] from baseline) of JNJ-38518168 at a dose of 100 mg/day for up to 12 weekscompared to placebo in subjects with active…
To estimate the efficacy of erlotinib administered as a single agent to chemo-naïve NSCLC patients as determined by the non progression rate (NPR) at 8 weeks.
The objective of the study is to assess image quality and diagnostic information of images during coronairy angiography with lower X-ray dose compared to standard dose.
The objective of the study is to asses image quality and diagnostic information of images during coronairy angiography with lower X-ray dose compared to standard dose.
The objective of the study is to assess image quality and diagnostic information in iliac angiography with a lower exposure dose.